Western Financial Corp’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,927
Closed -$497K 136
2026
Q1
$497K Sell
7,927
-11,768
-60% -$941K 0.19% 93
2025
Q4
$1.88M Buy
19,695
+524
+3% +$51.4K 0.74% 33
2025
Q3
$1.87M Buy
19,171
+1,574
+9% +$163K 0.81% 30
2025
Q2
$1.89M Buy
17,597
+9,465
+116% +$958K 1.01% 28
2025
Q1
$820K Sell
8,132
-159
-2% -$16K 0.48% 64
2024
Q4
$741K Buy
+8,291
New +$730K 0.41% 68

Other funds holding BSX

Western Financial Corp's BSX Position: Q2 2026 in Review

Western Financial Corp sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 7,927 shares — an estimated $497K sold.

Western Financial Corp first reported a position in BSX in Q4 2024 and held it in 6 quarters. The position peaked at $1.89M in Q2 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Western Financial Corp reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Western Financial Corp sold 7,927 Boston Scientific shares in Q2 2026, an estimated $497K.
  • Western Financial Corp first reported a position in Boston Scientific in Q4 2024 and held it in 6 quarters.
  • Western Financial Corp's Boston Scientific position peaked at $1.89M in Q2 2025.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Western Financial Corp's 13F filing for Q2 2026, filed 22 Jul 2026.